You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
A double blind randomized placebo controlled phase I/II study assessing the safety and efficacy of allogeneic bone marrow derived mesenchymal stem cell in critical limb ischemia
|
|---|---|
| Published in |
Journal of Translational Medicine, June 2013
|
| DOI | 10.1186/1479-5876-11-143 |
| Pubmed ID | |
| Authors |
Pawan K Gupta, Anoop Chullikana, Rajiv Parakh, Sanjay Desai, Anjan Das, Sanjay Gottipamula, Sagar Krishnamurthy, Naveen Anthony, Arun Pherwani, Anish S Majumdar |
| Abstract |
Peripheral vascular disease of the lower extremities comprises a clinical spectrum that extends from no symptoms to presentation with critical limb ischemia (CLI). Bone marrow derived Mesenchymal Stem Cells (BM- MSCs) may ameliorate the consequences of CLI due to their combinatorial potential for inducing angiogenesis and immunomodulatory environment in situ. The primary objective was to determine the safety of BM- MSCs in patients with CLI. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 200 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 3 | 2% |
| United Kingdom | 2 | 1% |
| France | 1 | <1% |
| Ukraine | 1 | <1% |
| Italy | 1 | <1% |
| Japan | 1 | <1% |
| Sri Lanka | 1 | <1% |
| Unknown | 190 | 95% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 32 | 16% |
| Student > Ph. D. Student | 26 | 13% |
| Student > Master | 24 | 12% |
| Other | 23 | 12% |
| Student > Bachelor | 19 | 10% |
| Other | 32 | 16% |
| Unknown | 44 | 22% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 60 | 30% |
| Agricultural and Biological Sciences | 28 | 14% |
| Biochemistry, Genetics and Molecular Biology | 26 | 13% |
| Nursing and Health Professions | 11 | 6% |
| Engineering | 11 | 6% |
| Other | 14 | 7% |
| Unknown | 50 | 25% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 June 2018.
All research outputs
#6,981,733
of 23,344,526 outputs
Outputs from Journal of Translational Medicine
#1,080
of 4,117 outputs
Outputs of similar age
#58,848
of 198,931 outputs
Outputs of similar age from Journal of Translational Medicine
#17
of 38 outputs
Altmetric has tracked 23,344,526 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 4,117 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one has gotten more attention than average, scoring higher than 73% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 198,931 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.
We're also able to compare this research output to 38 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 57% of its contemporaries.